Appendix 1 – Immunity Medicine

Skip to content

Home
C Difficile
Letter from CEO
Patient Interviews
Contact Us

Home
C Difficile
Letter from CEO
Patient Interviews
Contact Us

ImmuniMed Inc., is a clinical-stage Biopharmaceutical Company focused on developing novel Oral Dose Preventive and Therapeutic Antibodies for unmet medical needs.

Copyright © 2025 ImmuniMed Inc. | All rights reserved

Scroll to Top